Tachykinins and calcitonin gene-related peptide: co-existence in sensory nerves of the nasal mucosa and effects on blood flow.
The presence and co-existence of calcitonin gene-related peptide (CGRP)- and substance P (SP)-like immunoreactivity (-LI) in sensory neurons of the nasal mucosa and trigeminal ganglion in several vertebrate species, including man, were established using immunohistochemistry. In the nasal mucosa the CGRP- and SP-immunoreactive (IR) nerve fibers were localized within the epithelium, around arteries, arterioles, venules, venous sinusoids and close to exocrine elements, mainly ducts. Double-staining experiments revealed that the CGRP-LI-containing nerve profiles and cell bodies also contained SP-LI. In the pig, CGRP- and SP-IR fibers were also detected in the maxillary portion of the trigeminal nerve and around the sphenopalatine artery and vein, as well as around the nasal dorsal vein. The nasal mucosal content of CGRP-LI, as determined by radioimmunoassay, was almost 5-fold higher in the pig and guinea pig compared to man. The nasal CGRP-IR nerves disappeared after capsaicin pretreatment in the guinea pig. In the cat, local intra-arterial infusions of capsaicin, SP, neurokinin A (NKA), neuropeptide K (NPK) and CGRP caused a concentration-dependent increase in nasal blood flow. CGRP caused a longer-lasting vasodilatation than the tachykinins. In conclusion, the morphological findings of co-localization of CGRP-LI and SP-LI in capsaicin-sensitive nerve fibers of the nasal mucosa and trigeminal ganglia of different species including man, coupled with the in vivo description of the high vasodilator potency of CGRP and tachykinins, imply co-release of several vasoactive agents upon activation of the nasal sensory nerves. Furthermore, the similarity of the morphological findings among the different species indicates that experimental data from animals may reflect the existence of similar mechanisms in humans.
Stjärne
P
P
Department of Oto-Rhino-Laryngology, Karolinska Hospital, Stockholm, Sweden.
Lundblad
L
L
Anggård
A
A
Hökfelt
T
T
Lundberg
J M
JM
D000328:Adult; D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D001808:Blood Vessels / Q000294:innervation*; D015740:Calcitonin Gene-Related Peptide; D002415:Cats; D006168:Guinea Pigs; D006801:Humans; D007223:Infant; D009475:Neurons, Afferent / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism* / Q000494:pharmacology / Q000502:physiology; D009831:Olfactory Mucosa / Q000098:blood supply / Q000294:innervation*; D051381:Rats; D013552:Swine; D015320:Tachykinins / Q000378:metabolism* / Q000494:pharmacology / Q000502:physiology
D009479:Neuropeptides; D015320:Tachykinins; D015740:Calcitonin Gene-Related Peptide